Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective
This activity is for: Pharmacists
The National Eczema Association partnered with Pharmacy Times to create an educational activity designed to enhance pharmacists’ ability to optimize skincare and outcomes of atopic dermatitis through OTC options. The discussion also features the perspective of a caregiver of a patient living with atopic dermatitis who will provide additional insight into challenges faced with atopic dermatitis treatment.
This activity expires July 24, 2025.
Register now
Conversations in Primary Care 2025
This activity is for: Primary care physicians, nurse practitioners (NPs), and physician associates (PAs)
The National Eczema Association partnered with the National Association for Continuing Education (NACE) on a new educational activity to improve providers’ knowledge, competence, and performance in diagnosing and managing atopic dermatitis (AD) in the primary care setting. The program features expert-led, case-based discussions on the assessment, treatment, and long-term management of AD, with a focus on emerging therapies, patient communication, and reducing barriers to care.
This activity expires July 26, 2025
Register now
Derm Discussions: An Expert Roundtable Tackles Cases in IL-13 Inhibition for Moderate to Severe Atopic Dermatitis
This activity is for: Dermatologists, allergist/immunologists, nurse practitioners (NPs), and physician associates (PAs) practicing in dermatology and allergy
The National Eczema Association partnered with Clinical Education Alliance (Clinical Care Options and Practicing Clinicians Exchange) on a new educational activity to improve providers’ knowledge, competence, and performance in managing advanced therapies for patients with moderate to severe atopic dermatitis. The program features expert-led, case-based discussions on the role of interleukin-13 (IL-13) in AD pathophysiology and the clinical application of IL-13 inhibitors.
Learn more
Taking Action in Moderate to Severe Pediatric Atopic Dermatitis: Patient- and Caregiver-Centered Approaches to Improve Outcomes
This activity is for: Primary care physicians, nurse practitioners (NPs), and physician associates (PAs) who manage children with AD.
The National Eczema Association partnered with Clinical Education Alliance (Clinical Care Options and Practicing Clinicians Exchange) on a new educational activity to improve providers’ knowledge, competence, and performance in diagnosing and managing moderate to severe atopic dermatitis (AD) in pediatric patients within the primary care setting. The program features an expert-led, case-based webcast presentation focused on systemic therapies and the use of patient- and caregiver-reported outcomes to support person-centered care and improve long-term outcomes.
This activity expires on March 6, 2026
Learn more
